Literature DB >> 18449573

Patients' perceptions of having a central venous catheter or a totally implantable subcutaneous port system-results from a randomised study in acute leukaemia.

Eva Johansson1, Per Engervall, Hjördis Björvell, Robert Hast, Magnus Björkholm.   

Abstract

GOALS OF WORK: The selection process of type of central venous access device (CVAD) in patients with acute leukaemia (AL) is generally based on appropriate catheter capacity/function and risk of complications in relation to the planned length of therapy. Advantages and disadvantages of the CVAD from the patient's perspective should also be important parts in the selection of type of device. Perceptions on having a CVAD were thus analysed in a series of adult patients with AL included in a prospective randomised study evaluating the use of a double lumen totally implantable subcutaneous port system (PORT) or a double lumen central venous catheter (CVC) regarding survival time and complication rate.
MATERIALS AND METHODS: Perceptions were registered in 32 patients (median age 68 years, range 24-83 years) on three occasions (T1; the day after placement, T2; 3 weeks after placement and T3 after 12 weeks and/or when the CVAD was removed) with the use of two study specific questionnaires. MAIN
RESULTS: Overall, many patients reported minor catheter related discomfort, feelings of anxiety and restrictions. Half of the patients (6/11) who experienced a local bleeding after CVAD insertion described the placement procedure as unpleasant. More patients in the CVC group compared with the PORT group stated that they thought of having a CVAD (T3; p = 0.02) and that the CVAD interfered when dressing themselves (T2; p = 0.02 and T3; 0.04) or taking a shower (T3; p = 0.009).
CONCLUSION: Our findings support the view that the PORT is less restrictive in daily life than the CVC.

Entities:  

Mesh:

Year:  2008        PMID: 18449573     DOI: 10.1007/s00520-008-0449-6

Source DB:  PubMed          Journal:  Support Care Cancer        ISSN: 0941-4355            Impact factor:   3.603


  26 in total

1.  Totally implantable central venous access ports for high-dose chemotherapy administration and autologous stem cell transplantation: analysis of overall and septic complications in 68 cases using a single type of device.

Authors:  R Biffi; G Martinelli; S Pozzi; S Cinieri; E Cocorocchio; F Peccatori; P F Ferrucci; R Pistorio; B Andreoni
Journal:  Bone Marrow Transplant       Date:  1999-07       Impact factor: 5.483

2.  Double lumen port access in patients receiving allogeneic blood stem cell transplantation.

Authors:  U Platzbecker; T Illmer; M Schaich; J Freiberg-Richter; A Helwig; R Plettig; A Jenke; G Ehninger; M Bornhäuser
Journal:  Bone Marrow Transplant       Date:  2001-12       Impact factor: 5.483

3.  Central vascular access devices in oncology and hematology considered from a different point of view: how do patients experience their vascular access ports?

Authors:  Godelieve A Goossens; Marc Vrebos; Marguerite Stas; Ivo De Wever; Lutgarde Frederickx
Journal:  J Infus Nurs       Date:  2005 Jan-Feb

4.  Guidelines for the prevention of intravascular catheter-related infections. Centers for Disease Control and Prevention.

Authors:  Naomi P O'Grady; Mary Alexander; E Patchen Dellinger; Julie L Gerberding; Stephen O Heard; Dennis G Maki; Henry Masur; Rita D McCormick; Leonard A Mermel; Michele L Pearson; Issam I Raad; Adrienne Randolph; Robert A Weinstein
Journal:  MMWR Recomm Rep       Date:  2002-08-09

5.  Classical external indwelling central venous catheter versus totally implanted venous access systems for chemotherapy administration: a randomized trial in 100 patients with solid tumors.

Authors:  P Carde; M F Cosset-Delaigue; A Laplanche; I Chareau
Journal:  Eur J Cancer Clin Oncol       Date:  1989-06

6.  Totally implantable venous access devices in cystic fibrosis: complications and patients' opinions.

Authors:  H C Rodgers; K Liddle; S J Nixon; J A Innes; A P Greening
Journal:  Eur Respir J       Date:  1998-07       Impact factor: 16.671

7.  Prevention of central venous catheter-related infections by using maximal sterile barrier precautions during insertion.

Authors:  I I Raad; D C Hohn; B J Gilbreath; N Suleiman; L A Hill; P A Bruso; K Marts; P F Mansfield; G P Bodey
Journal:  Infect Control Hosp Epidemiol       Date:  1994-04       Impact factor: 3.254

8.  Increased incidence of central venous catheter-related infections in bone marrow transplant patients.

Authors:  Y K Keung; K Watkins; S C Chen; S Groshen; A M Levine; D Douer
Journal:  Am J Clin Oncol       Date:  1995-12       Impact factor: 2.339

9.  Implantable devices for venous access: nurses' and patients' evaluation of three different port systems.

Authors:  A Lilienberg; M Bengtsson; H Starkhammar
Journal:  J Adv Nurs       Date:  1994-01       Impact factor: 3.187

10.  Granulocyte-macrophage colony-stimulating factor to increase efficacy of mitoxantrone, etoposide and cytarabine in previously untreated elderly patients with acute myeloid leukaemia: a Swedish multicentre randomized trial.

Authors:  C Löfgren; C Paul; M Aström; R Hast; M Hedenius; R Lerner; J Liliemark; I Nilsson; S Rödjer; B Simonsson; D Stockelberg; U Tidefelt; M Björkholm
Journal:  Br J Haematol       Date:  2004-02       Impact factor: 6.998

View more
  13 in total

1.  Improving cancer patients' knowledge about totally implantable access port: a randomized controlled trial.

Authors:  Michela Piredda; Valentina Biagioli; Diana Giannarelli; Daniele Incletoli; Francesca Grieco; Massimiliano Carassiti; Maria Grazia De Marinis
Journal:  Support Care Cancer       Date:  2015-07-24       Impact factor: 3.603

2.  Pain reduction in children during port-à-cath catheter puncture using local anaesthesia with EMLA™.

Authors:  Birke Lüllmann; Johannes Leonhardt; Martin Metzelder; Ludwig Hoy; Heidrun Gerr; Christin Linderkamp; Christoph Klein; Lorenz Grigull
Journal:  Eur J Pediatr       Date:  2010-07-10       Impact factor: 3.183

3.  Percutaneous image-guided implantation of totally implantable venous access ports in the forearm or the chest? A patients' point of view.

Authors:  Jan Peter Goltz; Bernhard Petritsch; Johannes Kirchner; Dietbert Hahn; Ralph Kickuth
Journal:  Support Care Cancer       Date:  2012-07-25       Impact factor: 3.603

Review 4.  Totally implantable vascular access devices 30 years after the first procedure. What has changed and what is still unsolved?

Authors:  Roberto Biffi; Adriana Toro; Simonetta Pozzi; Isidoro Di Carlo
Journal:  Support Care Cancer       Date:  2014-06       Impact factor: 3.603

5.  The duration of functioning of a subcutaneous implantable port for the treatment of hematological tumors: a single institution-based study.

Authors:  Hitoshi Ohno; Chisaki Mizumoto; Yoshihiro Otsuki; Shigeru Oguma; Yataro Yoshida
Journal:  Int J Clin Oncol       Date:  2010-03-02       Impact factor: 3.402

6.  No impact of central venous insertion site on oncology patients' quality of life and psychological distress. A randomized three-arm trial.

Authors:  Roberto Biffi; Franco Orsi; Simonetta Pozzi; Andrea Maldifassi; Davide Radice; Nicole Rotmensz; Maria Giulia Zampino; Nicola Fazio; Giulia Peruzzotti; Florence Didier
Journal:  Support Care Cancer       Date:  2010-08-28       Impact factor: 3.603

7.  Morbidity of chemotherapy administration and satisfaction in breast cancer patients: a comparative study of totally implantable venous access device (TIVAD) versus peripheral venous access usage.

Authors:  Kul Ranjan Singh; Gaurav Agarwal; Gitika Nanda; Gyan Chand; Anjali Mishra; Amit Agarwal; Ashok K Verma; Saroj K Mishra; Puneet Goyal
Journal:  World J Surg       Date:  2014-05       Impact factor: 3.352

8.  Living with a peripherally inserted central catheter: the perspective of cancer outpatients-a qualitative study.

Authors:  Paula Parás-Bravo; María Paz-Zulueta; Miguel Santibañez; Cesar Fernández-de-Las-Peñas; Manuel Herrero-Montes; Vanesa Caso-Álvarez; Domingo Palacios-Ceña
Journal:  Support Care Cancer       Date:  2017-07-13       Impact factor: 3.603

Review 9.  Randomized controlled trials in central vascular access devices: A scoping review.

Authors:  Mari Takashima; Gillian Ray-Barruel; Amanda Ullman; Samantha Keogh; Claire M Rickard
Journal:  PLoS One       Date:  2017-03-21       Impact factor: 3.240

10.  Implantable Port Devices, Complications and outcome in Pediatric Cancer, a Retrospective Study.

Authors:  H Esfahani; M Ghorbanpor; A Tanasan
Journal:  Iran J Ped Hematol Oncol       Date:  2016-03-15
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.